There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution (16 vs 19 days; HR, 1.20) through 28 days and cut the number of ...

Remdesivir plus dexamethasone vs dexamethasone alone reduces the risk of mortality among patients hospitalized with COVID-19.

Other companies are developing oral antivirals for COVID-19, notably Merck & Co and Ridgeback Biotherapeutics' molnupiravir and Pfizer's PF-07321332, which have both just moved into phase 3 ...

Vitamin D may lower ICU and intubation rates in COVID-19 patients, with significant benefits observed in older and severe ...

Oral antivirals are highly anticipated because ... and a booking system for telehealth consultations. Any prescribed COVID-19 medication will be dispensed with overnight shipping or routing ...

NORTH CAROLINA (WTVD) -- The CDC is warning that viruses will spread over the next couple of months. Agency leaders are ...

Flu has a different treatment than COVID-19, but antivirals for either should be started immediately. RSV is a common virus that causes only mild symptoms in most adults, such as a runny nose ...

Illinois health officials receive flu and COVID-19 vaccinations, emphasizing the importance of immunization before the ...

Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control ...